Dr. David Engle, MD
Claim this profileBaptist Memorial Hospital
Studies Endometrial Cancer
Studies Adenocarcinoma
3 reported clinical trials
12 drugs studied
Area of expertise
1Endometrial Cancer
Stage III
Stage IV
2Adenocarcinoma
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials David Engle, MD is currently running
Targeted Therapy + Atezolizumab
for Endometrial Cancer
This trial tests drugs that target cancer cells, sometimes combined with an immune-boosting drug called atezolizumab. It focuses on patients with endometrial cancer that has returned or is persistent. The drugs are chosen based on the genetic profile of the patient's tumor to improve effectiveness.
Recruiting1 award Phase 1 & 25 criteria
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
More about David Engle, MD
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments David Engle, MD has experience with
- Letrozole
- Talazoparib
- Inavolisib
- Atezolizumab
- Trastuzumab Emtansine
- Tiragolumab
Breakdown of trials David Engle, MD has run
Endometrial Cancer
Adenocarcinoma
Serous Cystadenocarcinoma
Ovarian Cancer
Fallopian Tube Serous Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Engle, MD specialize in?
David Engle, MD focuses on Endometrial Cancer and Adenocarcinoma. In particular, much of their work with Endometrial Cancer has involved Stage III patients, or patients who are Stage IV.
Is David Engle, MD currently recruiting for clinical trials?
Yes, David Engle, MD is currently recruiting for 2 clinical trials in Memphis Tennessee. If you're interested in participating, you should apply.
Are there any treatments that David Engle, MD has studied deeply?
Yes, David Engle, MD has studied treatments such as Letrozole, Talazoparib, Inavolisib.
What is the best way to schedule an appointment with David Engle, MD?
Apply for one of the trials that David Engle, MD is conducting.
What is the office address of David Engle, MD?
The office of David Engle, MD is located at: Baptist Memorial Hospital, Memphis, Tennessee 38120 United States. This is the address for their practice at the Baptist Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.